Measles spreading rapidly across Europe, WHO calls for urgent curbs
HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team February 4, 2024: Measles cases rose 30-fold in Europe with more than 30,000 people being infected by the contagious viral disease.
HQ Team February 3, 2024: A child’s brain gets excessively or abnormally active when they are not treated for anxiety disorders, according to.
HQ Team February 3, 2024: New research from the University of São Paulo’s Ribeirão Preto Medical School suggests that excessive stress during adolescence.
Bharti Jayshankar February 3, 2024: In a recent study published in the journal Neurology, researchers have uncovered a potential association between polycystic ovary.
HQ Team February 2, 2024: The Centers for Disease Control (CDC) reports that syphilis cases in the United States have reached their highest.
Bharti Jayshankar February 2, 2024: A new study has come up with an explanation for the heightened susceptibility of women to autoimmune diseases.
Bharti Jayshankar February 2, 2024: As urban farming gains momentum as a solution to environmental and health challenges, a recent international collaboration delves.
HQ Team February 1, 2024: Cardio exercise can play a role in lowering the incidence of prostate cancer, according to new research. The.
Philips’ recalled ventilators and machines for treating obstructive sleep apnea have caused 561 deaths, according to the USFDA.
Biogen, a US-based biotechnology company, will discontinue the development and commercialisation of its Alzheimer’s treatment and terminate its post-approval study as it failed.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com